CENTEK announced that its subsidiary Shandong Huasu Pharmaceutical Co., Ltd.'s "Succinic Acid Metoprolol Active Pharmaceutical Ingredient" has passed the technical review by the National Medical Products Administration's Drug Evaluation Center and has received the "Approval Notice for the Market Application of Chemical Active Pharmaceutical Ingredients" issued by the National Medical Products Administration. The approval for this active pharmaceutical ingredient provides a stable source of raw materials for the company's research on succinic acid metoprolol sustained-release capsules, positively impacting the company's operating performance
